Discover CME, tools, and guideline-focused education to improve your knowledge - and patient outcomes.
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
Vera Bril, MD
Nicholas J. Silvestri, MD
Diagnostic Advances in gMG: Effective Tools and Techniques
Hans Katzberg, MD
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
New Frontiers in MG: How FcRn Antagonists Are Changing MG Therapy
Ocular to Generalized MG: How and Why the Disease Evolves
Managing Side Effects in FcRn Therapy: Best Practices for gMG
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
April 29, 2025
San Diego, California
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
May 01, 2025
Washington, DC, District of Columbia
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Jonathan Strober, MD
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Personalizing Care Within the RCC Treatment Paradigm
Eric Jonasch, MD
Brad McGregor, MD
Ulka Vaishampayan, MBBS
What’s New in Subconjunctival MIBS
Paul Petrakos, DO, MS
I. Paul Singh, MD
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
What’s New in Glaucoma Topical Therapies?
Justin Schweitzer, OD, FAAO
Sarah H. Van Tassel, MD
What’s New in Schlemm’s Canal MIGS?
What’s New With 3D Visualization in Glaucoma Surgery?
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
Revolutionizing Diagnostic Precision: AI-Driven Approaches in Digital Pathology and HER2 Expression
Marilyn Yuanxin Ma Bui, MD, PhD
Anne Vincent-Salomon, MD
Chairperson’s Perspective: Treating At-Risk MASH: What Are You Waiting For?
Mazen Noureddin, MD, MHSc
New Solutions for Optimizing IOP Control: A Case-Based Approach
What’s New in Glaucoma Therapy?
Effective MIGS for Optimal IOP Control: A Case-Based Approach
World Obesity Day: Call to Action
Donna Ryan, MD
Ricardo Cohen, MD, PhD
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.